The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBatm Advanced Regulatory News (BVC)

Share Price Information for Batm Advanced (BVC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.675
Bid: 18.35
Ask: 19.00
Change: -0.075 (-0.40%)
Spread: 0.65 (3.542%)
Open: 18.75
High: 0.00
Low: 0.00
Prev. Close: 18.75
BVC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

13 Sep 2010 07:00

RNS Number : 5190S
BATM Advanced Communications Ld
13 September 2010
 



13 September 2010

 

BATM Advanced Communications Limited

Interim Management Statement

BATM Advanced Communications Limited ("BATM" or the "Company") (LSE: BVC), a leading designer and producer of broadband data and telecoms systems and medical laboratory systems, is today issuing its Interim Management Statement for the period from 1 July 2010 to 31 August 2010.

Current trading update 

Total revenues in the first two months of the second half of 2010 were $ 18.6 million, compared with $19.1 million in the equivalent period in 2009. Revenues for the period are broadly inline with those of the equivalent period in 2009 and also with management's expectations.

During these two months the sales mix was 68% from the Telecoms division and 32% from the Medical division as compared to 75% and 25% in the second half of 2009 and 65% and 35% in the first half of 2010.

The gross margin has slightly increased during the first two months of the second half of 2010 over the first half of 2010.

 

Financial position 

The Company's balance sheet remains very strong and at the end of August the effective cash balance stood at $53.4 million, a decrease of $9.4 million compared to the position at 30 June 2010, largely due to the Dividend payment in July amounted to $8.8 million and a slightly increase in inventory balances. 

Outlook Despite the decline of revenues from OEM sales, substantial orders have been received from Tier 1 customers in the US and higher demand for backhaul bandwidth, believed to be mainly due to the introduction of the Iphone4. BATM expects this demand to continue and is ramping up production so deliveries could be accelerated in Q4.

The medical division continues to make progress as was observed in H1 results. Field trials that started with the ISS (Electronically controlled Medical waste disposal) show very good results with orders received for units even before trials are completed. Management remains confident it will achieve its forecasts for the full year 2010 as published in our H1 report.

BATM will conduct a detailed investors and analysts meeting in London on 13 September giving details of its strategy and sales prospects for the years 2011-2013. Presentation materials have been posted in the Investors section of the BATM website.

 

- ends -

 

Enquiries

 

BATM Advanced Communications +972 9866 2525

Dr Zvi Marom, Chief Executive

Threadneedle Communications 020 7653 9850

Josh Royston / Graham Herring

Singer Capital Markets Ltd 020 3205 7626 

Shaun Dobson

Shore Capital 020 7408 4090 

Pascal Keane

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBSGDCRDBBGGG
Date   Source Headline
2nd May 20247:00 amRNSBATM selected for TB diagnostics programme
18th Apr 20247:00 amRNSBATM to deliver Edgility to new Tier 1 customer
8th Apr 20247:00 amRNSBATM awarded new Edgility contract from Cemex
3rd Apr 20247:00 amRNSAnnual Financial Report
26th Mar 20247:00 amRNSBATM receives $2.3m cyber security orders
12th Mar 20247:00 amRNSFull Year Results
29th Feb 20247:00 amRNSNotice of Results
2nd Jan 20247:00 amRNSTotal Voting Rights
30th Nov 20237:03 amRNSBlock Listing Application
27th Nov 20237:00 amRNSBlock Listing Interim Review
30th Oct 20237:00 amRNSBATM receives $3m cyber security order
23rd Oct 20237:00 amRNSADOR Diagnostics secures $7.5m investment
16th Oct 20233:30 pmRNSHolding(s) in Company
16th Oct 20233:30 pmRNSHolding(s) in Company
16th Oct 20237:00 amRNSNew Edgility order for US Emergency Services
9th Oct 20237:00 amRNSResponse to recent developments in Israel
6th Sep 20237:00 amRNSBATM receives $3.4m cyber security contract
29th Aug 20237:00 amRNSInterim Results
13th Jul 202311:30 amRNSResult of AGM and Director Appointment
8th Jun 20237:00 amRNSNotice of Annual General Meeting
6th Jun 20237:00 amRNSCapital Markets Day
5th Jun 20237:00 amRNSNew contract win for Edgility
10th May 20232:30 pmRNSCapital Markets Day and Investor Presentation
17th Apr 20237:00 amRNSEdgility rollout progressing ahead of schedule
4th Apr 20233:30 pmRNSAnnual Financial Report
6th Mar 20237:00 amRNSFull Year Results
24th Feb 20237:00 amRNSNotice of Results
1st Feb 20237:00 amRNSAppointment of Chief Financial Officer
9th Jan 20237:00 amRNSBATM receives $26m cyber security order
3rd Jan 20233:30 pmRNSGrant of Options
21st Dec 202212:00 pmRNSResult of AGM
21st Dec 20227:00 amRNSTransaction in Own Shares and TVR
20th Dec 20227:00 amRNSTransaction in Own Shares and TVR
19th Dec 20227:00 amRNSTransaction in Own Shares and TVR
16th Dec 20227:00 amRNSTransaction in Own Shares and TVR
15th Dec 20227:00 amRNSTransaction in Own Shares and TVR
14th Dec 20227:00 amRNSTransaction in Own Shares and TVR
13th Dec 20227:00 amRNSTransaction in Own Shares and TVR
9th Dec 20227:00 amRNSTransaction in Own Shares and TVR
8th Dec 20227:00 amRNSTrading Update
25th Nov 20221:00 pmRNSBlock Listing Interim Review
24th Nov 20224:00 pmRNSNotice of Annual General Meeting
27th Oct 20227:00 amRNSADOR and BIOASTER to develop STI diagnostic tests
18th Oct 20227:00 amRNSMulti-year contract with CityFibre for Edgility
6th Oct 20227:00 amRNSDirectorate Changes
24th Aug 20227:00 amRNSInterim Results
19th Jul 20227:00 amRNSAppointment of CEO of ADOR Diagnostics
11th Jul 20227:00 amRNSBATM partners with CityFibre for Edgility
16th Jun 20224:36 pmRNSPrice Monitoring Extension
26th May 20227:00 amRNSBlock Listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.